Intrinsic Value of S&P & Nasdaq Contact Us

Adial Pharmaceuticals, Inc. WT EXP 073123 ADILW NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
36/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Adial Pharmaceuticals, Inc. WT EXP 073123 (ADILW) has 9 known insider and institutional holders on record. The largest holder is Claiborne Cary J with 300,000 shares. Other notable holders include Truluck Joseph and Stilley William B. III.

ADILW Insider Ownership

Top Holder
Claiborne Cary J
300,000 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Claiborne Cary J Chief Executive Officer 300,000 2023-05-25
100%
2 Truluck Joseph Chief Financial Officer 125,000 2023-05-25
42%
3 Stilley William B. Iii Director 50,000 2023-05-25
17%
4 Goodman Tony Director 50,000 2023-05-25
17%
5 Anderson J. Kermit Director 50,000 2023-05-25
17%
6 Newman James W. Jr. Director 50,000 2023-05-25
17%
7 Gilliland Robertson H. Director 50,000 2023-05-25
17%
8 Johnson Bankole A. Director 40,000 2023-06-02
13%
9 Schuyler Kevin Director 700 2023-10-03
0%

No ownership data available for ADILW.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message